UPDATED Apr 25, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
TCFC | US$27.09 | -2.7% | -25.3% | US$153.6m | US$37.00 | PB0.8x | n/a | 2.6% | ||
PBIP | US$15.13 | -0.7% | 9.6% | US$117.7m | US$15.00 | PB1x | E87.9% | 1.9% | ||
CWBC | US$15.48 | 2.2% | 22.3% | US$137.0m | US$18.00 | PB1.2x | n/a | 2.1% | ||
GSBX | US$21.00 | 0% | 10.5% | US$46.5m | n/a | PB0.8x | n/a | n/a | ||
TYBT | US$94.00 | 0% | n/a | US$102.1m | n/a | PB2x | n/a | 1.9% | ||
RBAZ | US$11.40 | 0% | 46.2% | US$20.3m | n/a | PB1x | n/a | 0% | ||
CFSB | US$6.89 | -5.4% | -1.6% | US$44.1m | n/a | PB0.6x | n/a | n/a | ||
IROQ | US$16.32 | -0.02% | 6.0% | US$52.4m | n/a | PB0.7x | n/a | 2.5% | ||
CHMG | US$43.50 | 10.3% | 8.1% | US$208.1m | US$48.00 | PB1x | E1.7% | 2.9% | ||
FRFC | US$35.36 | -0.9% | n/a | US$19.1m | n/a | PB0.8x | n/a | 3.6% | ||
ELMA | US$19.00 | 0.5% | n/a | US$21.7m | n/a | PB0.7x | n/a | 2.1% | ||
SFDL | US$23.00 | 4.5% | -5.0% | US$74.3m | n/a | PB0.8x | n/a | 2.3% | ||
SOMC | US$17.00 | 1.5% | -8.1% | US$77.9m | n/a | PB0.8x | n/a | 3.5% | ||
SFBC | US$39.15 | -2.7% | 5.0% | US$99.5m | n/a | PB1x | n/a | 1.9% | ||
PNBI | US$23.32 | 0% | 0.7% | US$23.2m | n/a | PB0.7x | n/a | 4.3% | ||
MBBC | US$9.06 | 0% | -10.4% | US$19.5m | n/a | PB0.6x | n/a | n/a | ||
MCBC | US$14.33 | 3.5% | 49.0% | US$491.4m | US$12.33 | PB1.7x | E1.0% | 2.5% | ||
MCHT | US$7.41 | 6.0% | -7.3% | US$24.7m | n/a | PE8.2x | n/a | 4.6% | ||
NWPP | US$2.48 | 0% | 10.2% | US$58.8m | n/a | PB0.9x | n/a | 2.8% | ||
CIBN | US$13.62 | -0.4% | -18.7% | US$10.8m | n/a | PB0.6x | n/a | 2.9% | ||
HCBC | US$30.46 | 1.0% | -6.9% | US$31.1m | n/a | PB0.8x | n/a | 6.6% | ||
SNNF | US$6.26 | -3.8% | -35.8% | US$11.6m | n/a | PB0.5x | n/a | n/a | ||
BAFN | US$12.80 | 1.1% | -11.7% | US$52.9m | n/a | PB0.6x | n/a | 2.5% | ||
FSUN | US$35.00 | 1.2% | 28.4% | US$960.5m | n/a | PB1.1x | n/a | n/a |